LMAX.TO
Get informed when a big investor buys or sells
+ Follow| Market cap | $217.22 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $1.71 (12.06%) |
| Earnings per Share | $- |
| Beta | 0.52 |
| Outstanding Shares | - |
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
LMAX aims to generate compelling monthly income by investing in an equally weighted portfolio of prominent healthcare firms, predominantly those operating in the U.S. large-cap market. To both lower overall risk and boost the income stre...